Trump picks White House aide Dr. Heidi Overton to lead FDA

Key Points:

• Dr. Heidi Overton, a supporter of former President Trump's health priorities, has been nominated to lead the FDA, with backing from Trump and Robert F. Kennedy Jr.'s "Make America Healthy Again" movement despite criticism from Democrats and some Senate Republicans.
• Overton's tenure is expected to focus on controversial issues including rolling back access to abortion pills, splitting the MMR vaccine into separate immunizations, and easing regulations on peptides, aligning with the priorities of conservative health advocates.
• She faces a challenging confirmation process in a narrowly Republican-led Senate and must address unfinished projects left by former FDA head Dr. Marty Makary, including regulation of ultraprocessed foods, flavored e-cigarettes, and controversial drug approvals.
• The FDA under Kennedy and Trump has taken a skeptical stance on vaccines and antidepressants, with ongoing reviews and restrictions that have drawn criticism from public health experts and industry stakeholders.
• The agency is also managing urgent public health issues such as multistate foodborne illness outbreaks linked to cyclospora in lettuce and salmonella in jalapeño peppers, adding to the complexity of Overton's prospective leadership.